ArticleJournal of imaging2026
Two-Stage Dynamic Synergistic Segmentation Method for Myocardial Pathology.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Myocardial scar and edema segmentation from multi-sequence cardiac magnetic resonance (MS-CMR) is important for myocardial infarction assessment, but remains challenging due to heterogeneous modal characteristics, severe class imbalance, and the small, ambiguous nature of pathological regions. To address these issues, a dynamic synergistic segmentation network (DSS-Net) is proposed for myocardial pathology segmentation. The framework adopts a coarse-to-fine strategy, in which a coarse stage first segments the myocardium to provide anatomical priors and region constraints, and a fine stage then delineates scar and edema within the myocardium-aware space. In addition, a Modality Dynamic Fusion Module (MDFM) is designed to adaptively emphasize pathology-relevant modal information, and a Stage Feature Aggregation Module (SFAM) is introduced to enhance cross-stage feature interactions and fine-grained lesion representation. Experiments on the MyoPS 2020 and MyoPS 2024 datasets demonstrate that DSS-Net achieves competitive and balanced performance, reaching Dice scores of 0.706 for scar and 0.753 for edema on MyoPS 2020. Additionally, compared with SOTA methods in the MyoPS 2020 Challenge, the proposed method attains comparable scar segmentation performance while maintaining a more balanced trade-off between sensitivity and specificity. These findings suggest that combining anatomical guidance with pathology-aware multi-modal learning is a promising strategy for robust myocardial pathology segmentation in MS-CMR images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.